Thrombotic aortic restenosis after transapical SAPIEN valve implantation

Journal of Cardiac Surgery

Volumn 29, Issue 2, 2014, Pages 204-208

  Pergolini, Amedeo ^a   Pino, Paolo Giuseppe ^a   Zampi, Giordano ^b   Polizzi, Vincenzo ^a   Musumeci, Francesco ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; HEPARIN;

AGED; ANTICOAGULANT THERAPY; AORTA PROSTHESIS; AORTA STENOSIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; DISEASE COURSE; DUAL CHAMBER PACEMAKER; DYSPNEA; EPISTAXIS; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE PERIOD; PROSTHETIC VALVE THROMBOSIS; RESTENOSIS; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VERY ELDERLY;

AGED, 80 AND OVER; ANTICOAGULANTS; AORTIC VALVE STENOSIS; ASPIRIN; BIOPROSTHESIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; MALE; PROSTHESIS FAILURE; RECURRENCE; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84895521723     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12275     Document Type: Article

References (17)

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation 2002; 106: 3006-3008.
2. Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: 1-Year outcome in 26 patients. J Thorac Cardiovasc Surg 2009; 137: 167-173.
3. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-763.
4. Walther T, Kasimir MT, Doss M, et al. One-year interim follow-up results of the TRAVERCE trial: The initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg 2010; 39: 532-537.
5. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
6. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-1695.
7. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496.
8. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: The European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011; 124: 425-433.
9. Gilard M, Eltchaninoff H, Iung B, et al. FRANCE 2 Investigators registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-1715.
10. Lefèvre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
11. Trepels T, Martens S, Doss M, et al. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 2009; 120: e23-e24.
12. Whitlock RP, Sun JC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141: e576S-e600S.
13. Kefer J, Astarci P, Renkin J, et al. Images and case reports in interventional cardiology. Thrombotic aortic restenosis after transapical SAPIEN valve implantation. Circ Cardiovasc Interv 2010; 3: 289-292.
14. Greason KL, Mathew V, Sarano ME, et al. Early transcatheter aortic valve thrombosis. J Card Surg 2013; 28: 264-266.
15. Latib A, Messika-Zeitoun D, Maisano F, et al. Reversible Edwards SAPIEN XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2013; 61: 787-789.
16. Cota L, Stabile E, Agrusta M, et al. Bioprostheses "thrombosis" after transcatheter aortic valve replacement. J Am Coll Cardiol 2013; 61: 789-791.
17. Pache G, Blanke P, Zeh W, et al. Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. Eur Heart J 2013; Aug 29. [Epub ahead of print]